NIS modulation by PI3K, Akt and mTORC1 inhibition
Update on Clinical Excellence Awards 2012

Decoding DNA finds breast tumor signatures that predict treatment response (EurekAlert, 10 June 2012)

11 Jun 2012

Researchers at Washington University School of Medicine, publishing in Nature, have identified mutations in the DNA of patients with advanced breast cancer that could help predict which women are most likely to benefit from treatment with aromatase inhibitors.

Full article

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read